Literature DB >> 34465876

Verification of immunology-related genetic associations in BPD supports ABCA3 and five other genes.

Felix Blume1, Holger Kirsten1,2, Peter Ahnert1, Trinad Chakraborty3, Arnd Gross1, Katrin Horn1,2, Mohammad Reza Toliat4, Peter Nürnberg4, Eva-Maria Westenfelder5, Wolfgang Goepel6, Markus Scholz7,8.   

Abstract

BACKGROUND: Inflammatory processes are key drivers of bronchopulmonary dysplasia (BPD), a chronic lung disease in preterm infants. In a large sample, we verify previously reported associations of genetic variants of immunology-related genes with BPD.
METHODS: Preterm infants with a gestational age ≤32 weeks from PROGRESS and the German Neonatal Network (GNN) were included. Through a consensus case/control definition, 278 BPD cases and 670 controls were identified. We identified 49 immunity-related genes and 55 single-nucleotide polymorphisms (SNPs) previously associated with BPD through a comprehensive literature survey. Additionally, a quantitative genetic association analysis regarding oxygen supplements, mechanical ventilation, and continuous positive air pressure (CPAP) was performed.
RESULTS: Five candidate SNPs were nominally associated with BPD-related phenotypes with effect directions not conflicting the original studies: rs11265269-CRP, rs1427793-NUAK1, rs2229569-SELL, rs1883617-VNN2, and rs4148913-CHST3. Four of these genes are involved in cell adhesion. Extending our analysis to all well-imputed SNPs of all candidate genes, the strongest association was rs45538638-ABCA3 with CPAP (p = 4.9 × 10-7, FDR = 0.004), an ABC transporter involved in surfactant formation.
CONCLUSIONS: Most of the previously reported associations could not be replicated. We found additional support for SNPs in CRP, NUAK1, SELL, VNN2, and ABCA3. Larger studies and meta-analyses are required to corroborate these findings. IMPACT: Larger cohort for improved statistical power to detect genetic associations with bronchopulmonary dysplasia (BPD). Most of the previously reported genetic associations with BPD could not be replicated in this larger study. Among investigated immunological relevant candidate genes, additional support was found for variants in genes CRP, NUAK1, SELL, VNN2, and CHST3, four of them related to cell adhesion. rs45538638 is a novel candidate SNP in reported candidate gene ABC-transporter ABCA3. Results help to prioritize molecular candidate pathomechanisms in follow-up studies.
© 2021. The Author(s).

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34465876      PMCID: PMC9411063          DOI: 10.1038/s41390-021-01689-y

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.953


  83 in total

1.  Major contributors to hospital mortality in very-low-birth-weight infants: data of the birth year 2010 cohort of the German Neonatal Network.

Authors:  G Stichtenoth; M Demmert; B Bohnhorst; A Stein; S Ehlers; F Heitmann; E Rieger-Fackeldey; D Olbertz; C Roll; M Emeis; M Mögel; H Schiffmann; C Wieg; J Wintgens; E Herting; W Göpel; C Härtel
Journal:  Klin Padiatr       Date:  2012-03-22       Impact factor: 1.349

2.  Selectin polymorphisms and perinatal morbidity in low-birthweight infants.

Authors:  László Derzbach; Géza Bokodi; András Treszl; Barna Vásárhelyi; Andras Nobilis; János Rigó
Journal:  Acta Paediatr       Date:  2006-10       Impact factor: 2.299

3.  Bronchopulmonary dysplasia - prevalence, severity and predictive factors in a national cohort of extremely premature infants.

Authors:  T Farstad; D Bratlid; S Medbø; T Markestad
Journal:  Acta Paediatr       Date:  2011-01       Impact factor: 2.299

4.  Heritability of bronchopulmonary dysplasia, defined according to the consensus statement of the national institutes of health.

Authors:  Pascal M Lavoie; Chandra Pham; Kerry L Jang
Journal:  Pediatrics       Date:  2008-09       Impact factor: 7.124

5.  Neutralizing inhibitors in the airways of naïve ferrets do not play a major role in modulating the virulence of H3 subtype influenza A viruses.

Authors:  Emma R Job; Angela Pizzolla; Thomas Nebl; Kirsty R Short; Yi-Mo Deng; Louise Carolan; Karen L Laurie; Andrew G Brooks; Patrick C Reading
Journal:  Virology       Date:  2016-04-26       Impact factor: 3.616

6.  Understanding mechanisms underlying human gene expression variation with RNA sequencing.

Authors:  Joseph K Pickrell; John C Marioni; Athma A Pai; Jacob F Degner; Barbara E Engelhardt; Everlyne Nkadori; Jean-Baptiste Veyrieras; Matthew Stephens; Yoav Gilad; Jonathan K Pritchard
Journal:  Nature       Date:  2010-03-10       Impact factor: 49.962

7.  Genetic Contributions to the Development of Complications in Preterm Newborns.

Authors:  Chiara Poggi; Betti Giusti; Elena Gozzini; Alice Sereni; Ilaria Romagnuolo; Ada Kura; Elisabetta Pasquini; Rosanna Abbate; Carlo Dani
Journal:  PLoS One       Date:  2015-07-14       Impact factor: 3.240

8.  UCSC Genome Browser enters 20th year.

Authors:  Christopher M Lee; Galt P Barber; Jonathan Casper; Hiram Clawson; Mark Diekhans; Jairo Navarro Gonzalez; Angie S Hinrichs; Brian T Lee; Luis R Nassar; Conner C Powell; Brian J Raney; Kate R Rosenbloom; Daniel Schmelter; Matthew L Speir; Ann S Zweig; David Haussler; Maximilian Haeussler; Robert M Kuhn; W James Kent
Journal:  Nucleic Acids Res       Date:  2020-01-08       Impact factor: 16.971

9.  An integrated map of genetic variation from 1,092 human genomes.

Authors:  Goncalo R Abecasis; Adam Auton; Lisa D Brooks; Mark A DePristo; Richard M Durbin; Robert E Handsaker; Hyun Min Kang; Gabor T Marth; Gil A McVean
Journal:  Nature       Date:  2012-11-01       Impact factor: 49.962

10.  Integration of Genome-Wide SNP Data and Gene-Expression Profiles Reveals Six Novel Loci and Regulatory Mechanisms for Amino Acids and Acylcarnitines in Whole Blood.

Authors:  Ralph Burkhardt; Holger Kirsten; Frank Beutner; Lesca M Holdt; Arnd Gross; Andrej Teren; Anke Tönjes; Susen Becker; Knut Krohn; Peter Kovacs; Michael Stumvoll; Daniel Teupser; Joachim Thiery; Uta Ceglarek; Markus Scholz
Journal:  PLoS Genet       Date:  2015-09-24       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.